Can gut bacteria cause postpartum depression?

Recent research suggests a potential causal link between specific gut bacteria, blood metabolism, and the development of postpartum depression. By analyzing massive genetic databases, scientists mapped how microbial communities alter genetic switches and cholesterol levels to influence maternal mental health. The findings were published in the Journal of Affective Disorders.

Postpartum depression affects roughly 14 percent of people after giving birth. The condition impacts maternal quality of life and infant attachment. Currently, treatments remain limited because the biological mechanisms driving the disorder are not entirely understood. By the time symptoms emerge, physicians have few tools to reverse the condition.

Emerging evidence points toward the gut microbiome as a major factor in mood and brain health. Trillions of bacteria living in the digestive tract produce chemicals that communicate with the brain. This connection is often called the gut-brain axis. It regulates everything from immune responses to the maintenance of the blood-brain barrier.

Under normal conditions, intestinal microbes also facilitate the production of neurotransmitters like serotonin and essential energy sources called short-chain fatty acids. During pregnancy and after childbirth, the maternal digestive system undergoes profound remodeling. Researchers suspect that shifts in this bacterial landscape alter the ways the body processes hormones, steroids, and energy.

Zhiyuan Zhang, a researcher at Tongji University in Shanghai, and colleagues sought to map how these gut microbes interact with the host’s metabolism. They wanted to see if specific bacteria drive postpartum depression through blood metabolites and genetic switches.

To investigate this chain of events without the confounding factors of clinical trials, Zhang and colleagues used a technique known as Mendelian randomization. This approach relies on the natural, random assortment of genetic variations passed down during conception. Scientists use these genetic differences as a proxy to test if a specific exposure actually causes a disease, rather than just appearing alongside it.

Because genes are inherited randomly and cannot be altered by a person’s diet or environment later in life, they serve as an objective anchor for observing biological cause and effect. It allows researchers to bypass lifestyle differences that usually obscure nutritional and microbial studies.

The team pulled information from multiple large-scale global databases. They integrated genetic details from the MiBioGen consortium, a massive database covering tens of thousands of individuals, looking at genetic variations linked to the abundance of specific gut bacteria. They then cross-referenced these variations with genetic data from the FinnGen consortium, which included over 13,000 women who had experienced postpartum depression.

In another phase of the study, the investigators looked for biological mediators in the blood. They searched for circulating molecules that might carry signals from the gut to the brain by examining the UK Biobank dataset. In total, they examined 249 different measures of lipids, fatty acids, and small molecules like amino acids.

Finally, they assessed epigenetic factors, which are chemical tags on DNA that turn gene activity up or down without changing the genetic code itself. Specifically, the researchers examined DNA methylation, a process where tiny chemical clusters attach to genes to modify how much of a certain protein the body produces. They analyzed whether variations in these methylation patterns in blood tissue overlapped with the genetic risks for postpartum depression and gut bacteria levels.

The researchers identified totally different roles for various groups of bacteria. Six bacterial groups were associated with an elevated risk of developing postpartum depression. These included the class Clostridia, the order Bifidobacteriales, and several specific genera like Eggerthella. Conversely, a group known as the phylum Verrucomicrobia appeared to exert a protective effect against the disorder.

The team then traced how some of these bacteria influence mental health by looking at blood chemistry. They found that certain fats connected to high-density lipoprotein, commonly known as good cholesterol, acted as an intermediary. Higher levels of Bifidobacteriales reduced the presence of these cholesterol-related fats in the bloodstream, which in turn correlated with an increased risk of postpartum depression.

The epigenetic analysis revealed seven specific genes involved in metabolism that appear to be regulated by DNA methylation in connection with the disease. One primary focus was a gene that produces an enzyme called ferredoxin reductase. This enzyme helps the body manufacture steroid hormones and other cellular compounds.

The results indicated that lower levels of DNA methylation near this gene led to increased enzyme production. This increase in the enzyme actually seemed to protect against postpartum depression. The researchers found that genetic variations affecting this enzyme also influenced the abundance of the Bifidobacterium genus in the gut.

Other identified genes govern different cellular networks, like the synthesis of creatine for brain energy or the transport of amino acids. For example, the analysis suggested that increased activity of a gene responsible for transporting the amino acid cysteine raises the susceptibility to postpartum depression. Another gene, which initiates signaling pathways for cell survival, also appeared to elevate disease risk when highly active.

An enzyme associated with synthesizing creatine emerged as another important factor. Elevated expression of the gene responsible for this enzyme showed a protective effect against postpartum depression. The analysis indicated that epigenetic methylation likely suppresses this gene, thereby increasing the vulnerability to maternal mood disorders.

Despite the extensive data, the study relies on observational genetic statistics rather than direct experiments. The Mendelian randomization method provides mathematically robust hypotheses, but it cannot completely confirm direct biochemical reactions in the human body. Actual confirmation requires physical laboratory tests and clinical trials.

The investigators noted that the genetic databases were predominantly derived from populations of European ancestry. This lack of diversity restricts the ability to generalize the results to other ethnic groups, who might possess different genetic and microbial profiles. The datasets for the gut microbiome also included general population data rather than being exclusive to postpartum individuals.

The researchers acknowledged that they could only categorize bacteria at the broader genus level because of database limitations. Different individual species within a single genus can sometimes have opposite biological effects. Future research will need to use more precise sequencing tools to identify the exact bacterial strains involved in maternal health.

Currently, traditional antidepressant treatments for postpartum depression carry limitations. These medications can take weeks to become effective and often produce adverse side effects that concern parents who are breastfeeding. Moving forward, scientists hope to recreate these microbial frameworks in animal models to watch the biological processes in real time.

Mapping out these specific bacteria and lipid pathways opens the door for targeted therapies. Specialized probiotics or dietary interventions might one day help balance the gut and prevent postpartum depression without relying entirely on traditional medications.

The study, “Host – gut microbial metabolic crosstalk in postpartum depression: A multiomics insight linking blood metabolites to epigenetic modulation,” was authored by Zhiyuan Zhang, Xiaobing Hu, Weimin Tao, Ruijing Ma, Yuhan Zheng, Xin Fang, Jiameng Gao, and Zhendong Xu.